On the stock market since 2013, it operates in the world of health and science. It has 12,717 employees. Now — the numbers.
This is an established company with proven profits.
No real growth (3% a year).
If every debt were paid off today, $143B would still be left in the vault — a solid cushion for hard times.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
There is $143B in the vault; even if every debt were paid off, $143B would remain.
It pays out $0.65 per share each year — regular cash for whoever holds the stock.
Over the last 3 years, sales grew only 3% a year on average. At this size, speeding back up is not easy.
On our five-subject report card, SZUKF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: SZUKF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.